A US$15 million grant towards the COVID-19 vaccine efficacy trial in South Africa was awarded to Novavax by the Bill & Melinda Gates Foundation.
As South Africa is experiencing a surge in COVID-19, the program will help assess the efficacy of the vaccine. The Phase 2 trial of the Novavax vaccine is being conducted in collaboration with Wits University. Novavax inc is known for developing vaccines for a broad range of infectious diseases.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.